montelukast
Jump to navigation
Jump to search
English[edit]
Etymology[edit]
From Mont(r)e(al) + -lukast (“leukotriene receptor antagonist”), named after the city of Montreal, where the drug was developed by Merck in 1991.
Pronunciation[edit]
- (General American) IPA(key): /ˌmɑn.təˈluːˌkæst/
Noun[edit]
montelukast (uncountable)
- (pharmacology) A leukotriene antagonist (trademark Singulair) used orally in the form of its sodium salt C35H35ClNNaO3S to treat asthma or to relieve the symptoms of seasonal allergic rhinitis.
Translations[edit]
leukotriene receptor antagonist
References[edit]
- “montelukast”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.
Spanish[edit]
Noun[edit]
montelukast m (plural montelukasts)